These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1692997)

  • 21. Prognostic significance of raised serum alpha-fetoprotein levels in twin pregnancies.
    Ghosh A; Woo JS; Rawlinson HA; Ferguson-Smith MA
    Br J Obstet Gynaecol; 1982 Oct; 89(10):817-20. PubMed ID: 6181803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four years' experience of maternal alpha-fetoprotein screening and its effect on the pattern of antenatal care.
    Ward RH; Fairweather DV; Whyley GA; Shirley IM; Lucas M
    Prenat Diagn; 1981 Apr; 1(2):91-101. PubMed ID: 6180424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum alpha-fetoprotein and previous neural tube defects.
    Wald N; Barker S; Peto R; Brock DJ; Bonnar J
    Br J Obstet Gynaecol; 1976 Mar; 83(3):213-6. PubMed ID: 56196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
    Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
    Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
    Sebire NJ; Spencer K; Noble PL; Hughes K; Nicolaides KH
    Br J Obstet Gynaecol; 1997 Jul; 104(7):849-51. PubMed ID: 9236655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of maternal serum AFP.
    Lancet; 1979 Nov; 2(8150):999-1000. PubMed ID: 91780
    [No Abstract]   [Full Text] [Related]  

  • 28. Avoidance of anencephalic and spina bifida births by maternal serum-alphafetoprotein screening.
    Ferguson-Smith MA; Rawlinson HA; May HM; Tait HA; Vince JD; Gibson AA; Robinson HP; Ratcliffe JG
    Lancet; 1978 Jun; 1(8078):1330-3. PubMed ID: 78097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse.
    Wilson RD
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S496-S511. PubMed ID: 28063560
    [No Abstract]   [Full Text] [Related]  

  • 30. The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
    Pettit BR; King GS
    Clin Biochem; 1984 Feb; 17(1):46-51. PubMed ID: 6200255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of measurement of maternal plasma alpha-fetoprotein levels as a screening test for fetal neural tube defects.
    Bond EB; Thompson W; Elwood JH; Cran GW
    Br J Obstet Gynaecol; 1977 Aug; 84(8):574-7. PubMed ID: 70214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
    Johnson AM; Palomaki GE; Haddow JE
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):9-11. PubMed ID: 1695816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers.
    Bernard JP; Cuckle HS; Bernard MA; Brochet C; Salomon LJ; Ville Y
    Am J Obstet Gynecol; 2013 Sep; 209(3):223.e1-5. PubMed ID: 23673229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.
    Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alpha-fetoproteins in obstetrics].
    Weitzel H
    Gynakologe; 1983 Sep; 16(3):148-54. PubMed ID: 6196260
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimation of the levels of amniotic fluid alpha fetoprotein (AFP) for the prenatal diagnosis of spina bifida and anencephaly.
    Shoro AA
    Methods Find Exp Clin Pharmacol; 1981; 3(6):391-5. PubMed ID: 6173555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some problems of alpha-fetoprotein screening.
    Bennett MJ; Blau K; Johnson RD; Chamberlain GV
    Lancet; 1978 Dec; 2(8103):1296-7. PubMed ID: 82794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience].
    Guibaud S; Capella-Bonnet M; Simplot A
    J Genet Hum; 1985 Sep; 33(3-4):339-45. PubMed ID: 2414399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.